Key Points
Analysts expect $1.60 EPS and $778.91M revenue on May 6.
Axon has beaten earnings estimates in recent quarters consistently.
Software segment growth and margin expansion are critical watch items.
B+ Meyka grade reflects growth potential balanced against execution risks.
AXON (Axon Enterprise, Inc.) reports earnings on May 6, 2026, after market close. Analysts expect $1.60 EPS and $778.91 million in revenue for the quarter. The Scottsdale-based law enforcement technology company has beaten earnings expectations in recent quarters, delivering strong revenue growth despite profit margin pressures. Meyka AI rates AXON with a grade of B+, reflecting solid fundamentals and analyst consensus. With a $31.73 billion market cap and stock trading at $393.75, investors are watching whether the company can maintain its growth trajectory in software and sensors alongside its core TASER business.
Earnings Estimates and Historical Performance
Analysts are expecting steady performance from Axon Enterprise as it reports Q1 2026 results. The $1.60 EPS estimate represents a slight decline from the $2.15 EPS reported in the previous quarter (Q4 2025), but remains above the $1.53 trailing twelve-month EPS. Revenue expectations of $778.91 million show modest growth from the $796.72 million posted last quarter, though this reflects normal seasonal patterns in law enforcement technology sales.
Recent Beat/Miss Pattern
Axon has demonstrated a strong track record of beating earnings expectations. In the last four quarters, the company exceeded EPS estimates in two consecutive reports: delivering $2.15 actual EPS versus $1.60 estimated in Q4 2025, and $2.12 actual EPS versus $1.45 estimated in Q3 2025. Revenue also beat estimates in both periods, with $796.72 million actual versus $755.56 million estimated in Q4, and $668.54 million actual versus $641.02 million estimated in Q3. This consistent outperformance suggests management has built strong operational momentum.
Quarterly Trend Analysis
The earnings trend shows volatility in profitability despite revenue growth. EPS peaked at $2.15 in Q4 2025, then declined to the current $1.60 estimate for Q1 2026. Revenue has grown 33.5% year-over-year, reaching $778.91 million from approximately $583 million a year ago. However, net income growth has lagged revenue growth at -66.9%, indicating margin compression from higher operating expenses and R&D investments. The company is investing heavily in software development and cloud infrastructure to support its digital evidence management platform.
Key Metrics and What to Watch
Investors should focus on several critical metrics when Axon reports earnings on May 6. The company’s profitability margins, software segment growth, and cash flow generation will determine whether the stock can recover from its -2.13% daily decline and -30.67% year-to-date drop.
Software and Sensors Segment Performance
Axon’s Software and Sensors segment is the growth engine driving future profitability. This division includes Axon Evidence (digital evidence management), Axon Signal (connected devices), and cloud-based solutions for law enforcement agencies. Analysts will scrutinize recurring revenue growth, customer retention rates, and average revenue per user (ARPU) metrics. The company’s $778.91 million revenue estimate includes contributions from both TASER hardware sales and high-margin software subscriptions. Strong software growth would justify the company’s elevated 257.38 P/E ratio and support the B+ Meyka grade.
Operating Margin Expansion
The company’s 0.04% net profit margin is concerningly low, reflecting heavy investment in R&D (22.5% of revenue) and sales/general/administrative expenses (37.2% of revenue). Investors should watch for signs of operating leverage as the company scales its cloud platform. Gross margins remain healthy at 59.7%, but operating margins have compressed significantly. Management guidance on margin improvement timelines will be critical for stock performance.
Cash Flow and Capital Allocation
Operating cash flow of $2.63 per share and free cash flow of $0.93 per share (trailing twelve months) show the company generates real cash despite accounting losses. Investors should monitor whether Axon maintains its $2.53 current ratio and strong balance sheet while funding growth initiatives. The company carries $1.99 billion in debt against $31.73 billion market cap, representing a manageable 5.9% debt-to-market-cap ratio.
Analyst Consensus and Market Expectations
Wall Street maintains a decidedly bullish stance on Axon Enterprise heading into earnings. The analyst consensus shows 17 Buy ratings, 2 Hold ratings, and zero Sell ratings, translating to a 3.0 consensus rating (where 1.0 is Strong Buy and 5.0 is Strong Sell). This overwhelming support reflects confidence in the company’s long-term growth prospects despite near-term profitability challenges.
Consensus Rating Breakdown
The 17 Buy recommendations significantly outnumber the 2 Hold ratings, indicating broad agreement that Axon’s software transition justifies current valuations. No analysts rate the stock as a Sell, suggesting confidence that the company will eventually achieve profitable scale. This consensus contrasts with the company’s internal rating of C+ based on fundamental metrics, highlighting the gap between analyst sentiment and traditional valuation metrics. The B+ Meyka grade factors in this analyst consensus alongside S&P 500 benchmark comparison, sector performance, financial growth, and key metrics.
Price Target Implications
While specific price targets were not provided, the analyst consensus suggests confidence in upside potential from current levels. The stock’s $393.75 price sits well below the $885.92 year high, creating a potential recovery opportunity if earnings meet or exceed expectations. The -36.6% one-year decline has created a valuation reset that many analysts view as attractive for long-term investors willing to wait for profitability improvements.
Meyka AI Grade and Investment Perspective
Meyka AI rates AXON with a grade of B+, reflecting a balanced assessment of the company’s fundamentals and growth prospects. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The B+ rating suggests the stock is suitable for growth-oriented investors but carries execution risk.
Grade Components and Rationale
The B+ grade reflects several positive factors: strong revenue growth (33.5% year-over-year), consistent earnings beats in recent quarters, overwhelming analyst support (17 Buy ratings), and a solid balance sheet with $2.53 current ratio. However, the grade acknowledges concerns including margin compression, elevated valuation multiples (257.38 P/E ratio), and the company’s transition from hardware to software profitability. The -30.67% year-to-date decline has reduced valuation risk, making the risk/reward more balanced than earlier in 2026.
What the Grade Means for Earnings
The B+ rating suggests investors should expect Axon to deliver on its growth narrative, but profitability improvements may take additional quarters. A beat on the $1.60 EPS estimate and strong software segment guidance would support the B+ rating and potentially drive stock recovery. Conversely, a miss on revenue or disappointing software growth would pressure the stock further. The grade is not a guarantee and reflects current market conditions; investors should conduct their own research before making decisions. These grades are not guaranteed and we are not financial advisors.
Final Thoughts
Axon Enterprise enters its May 6 earnings report with strong momentum from recent beats and overwhelming analyst support, though elevated valuations and margin pressures create near-term uncertainty. The $1.60 EPS estimate and $778.91 million revenue forecast represent modest sequential declines but reflect normal seasonality in law enforcement technology sales. With a B+ Meyka grade and 17 Buy ratings from analysts, the market expects Axon to continue executing its software transition strategy. Investors should focus on Software and Sensors segment growth, operating margin trends, and management guidance on profitability timelines. The stock’s **-30.67% year-to-date decli…
FAQs
What EPS and revenue are analysts expecting for Axon’s May 6 earnings?
Analysts expect $1.60 EPS and $778.91 million revenue for Q1 2026, down slightly from Q4 2025’s $2.15 EPS and $796.72 million, reflecting seasonal patterns in law enforcement technology sales cycles.
Has Axon beaten earnings estimates recently?
Yes. Q4 2025 delivered $2.15 actual EPS versus $1.60 estimated, and Q3 2025 posted $2.12 actual EPS versus $1.45 estimated. Revenue also beat in both periods, demonstrating consistent operational outperformance.
Why is Axon’s P/E ratio so high at 257.38?
The elevated P/E ratio reflects investor expectations for future profitability growth as Axon transitions to high-margin software subscriptions. Current earnings are depressed by heavy R&D (22.5% of revenue) and sales expenses (37.2% of revenue) needed for scaling.
What should investors watch for in the earnings report?
Monitor Software and Sensors segment growth, operating margin expansion, and cloud subscription revenue trends. Strong software growth and margin improvement would support the B+ Meyka grade and justify current valuations.
What does the B+ Meyka grade mean for Axon?
The B+ grade indicates Axon suits growth investors but carries execution risk. It reflects strong revenue growth and solid fundamentals while acknowledging margin pressures and elevated valuations. Not investment advice.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)